Cargando…

APC Promoter Hypermethylation as a Prognostic Marker in Breast Cancer Patients

BACKGROUND: Adenomatous polyposis coli (APC) promoter hypermethylation implicated in breast cancer development through Wnt signaling pathway, hypermethylation may result in inactivation of APC expression. This study aimed to investigated whether hypermethylation of APC promoter, the aggressive behav...

Descripción completa

Detalles Bibliográficos
Autores principales:	Saelee, Pensri, Pongtheerat, Tanett
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	West Asia Organization for Cancer Prevention 2020
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8046330/ https://www.ncbi.nlm.nih.gov/pubmed/33369461 http://dx.doi.org/10.31557/APJCP.2020.21.12.3627

Ejemplares similares

Role of GSTM1 Copy Number Variant in the Prognosis of Thai Colorectal Cancer Patients Treated with 5-FU-based Chemotherapy
por: Pongtheerat, Tanett, et al.
Publicado: (2016)

Reduced Expression of GPX3 in Breast Cancer Patients in Correlation with Clinical Significance
por: Saelee, Pensri, et al.
Publicado: (2020)

Adenomatous polyposis coli (APC) gene promoter hypermethylation in primary breast cancers
por: Jin, Z, et al.
Publicado: (2001)

The Association of pre-miR27a Gene Polymorphism and Clinicopathological Data in Thai Breast Cancer Patients
por: Sanguansin, Sirima, et al.
Publicado: (2023)

Early diagnostic potential of APC hypermethylation in esophageal cancer
por: Wang, Bujiang, et al.
Publicado: (2018)

Frequent Promoter Hypermethylation of the APC and RASSF1A Tumour Suppressors in Parathyroid Tumours
por: Juhlin, C. Christofer, et al.
Publicado: (2010)

MAL promoter hypermethylation as a novel prognostic marker in gastric cancer
por: Buffart, T E, et al.
Publicado: (2008)

TMEFF2 promoter hypermethylation is an unfavorable prognostic marker in gliomas
por: Xie, Sidi, et al.
Publicado: (2021)

Hypermethylation of APC2 Is a Predictive Epigenetic Biomarker for Chinese Colorectal Cancer
por: He, Yuan, et al.
Publicado: (2018)

Prognostic Relevance of Promoter Hypermethylation of Multiple Genes in Breast Cancer Patients
por: Sharma, Gayatri, et al.
Publicado: (2009)

Hypermethylated APC in serous carcinoma based on a meta-analysis of ovarian cancer
por: Shen, Chunyan, et al.
Publicado: (2016)

Is APC hypermethylation a diagnostic biomarker for bladder cancer? A meta-analysis
por: Han, Wei, et al.
Publicado: (2018)

Frequency and Association Of GSTM1 and GSTT1 Gene Polymorphisms with Survival in Breast Cancer Patients
por: Tangkheunkan, Phakarat, et al.
Publicado: (2020)

APC hypermethylation for early diagnosis of colorectal cancer: a meta-analysis and literature review
por: Liang, Tie-Jun, et al.
Publicado: (2017)

Analysis of hypermethylation and expression profiles of APC and ATM genes in patients with oral squamous cell carcinoma
por: Rigi-Ladiz, Mohammad Ayub, et al.
Publicado: (2011)

CDH22 hypermethylation is an independent prognostic biomarker in breast cancer
por: Martín-Sánchez, Esperanza, et al.
Publicado: (2017)

Frequent DNA Hypermethylation at the RASSF1A and APC Gene Loci in Prostate Cancer Patients of Pakistani Origin
por: Yaqinuddin, Ahmed, et al.
Publicado: (2013)

What are the roles of global DNA and APC 2 gene promotor hypermethylation in multiple myeloma?
por: Pehlivan, Sacide, et al.
Publicado: (2021)

Hypermethylation of BEND5 contributes to cell proliferation and is a prognostic marker of colorectal cancer
por: Lin, Ruo-Kai, et al.
Publicado: (2017)

Promoter hypermethylation profiling of distant breast cancer metastases
por: Schrijver, Willemijne A. M. E., et al.
Publicado: (2015)

Promoter Hypermethylation of the ATM Gene as a Novel Biomarker for Breast Cancer
por: Begam, Nasrin, et al.
Publicado: (2017)

Discovery and Validation of Hypermethylated Markers for Colorectal Cancer
por: Wei, Jiufeng, et al.
Publicado: (2016)

Prognostic Significance of Promoter DNA Hypermethylation of cysteine dioxygenase 1 (CDO1) Gene in Primary Breast Cancer
por: Minatani, Naoko, et al.
Publicado: (2016)

ADAM33 gene silencing by promoter hypermethylation as a molecular marker in breast invasive lobular carcinoma
por: Seniski, Gerusa G, et al.
Publicado: (2009)

Hypermethylated KLF9 Is An Independent Prognostic Factor For Favorable Outcome In Breast Cancer
por: Wang, Lei, et al.
Publicado: (2019)

Transgelin gene is frequently downregulated by promoter DNA hypermethylation in breast cancer
por: Sayar, Nilufer, et al.
Publicado: (2015)

Promoter Hypermethylation in White Blood Cell DNA and Breast Cancer Risk
por: Cho, Yoon Hee, et al.
Publicado: (2015)

Quantitative assessment of the association between APC promoter methylation and breast cancer
por: He, Keli, et al.
Publicado: (2016)

Potential diagnostic and prognostic values of detecting promoter hypermethylation in the serum of patients with gastric cancer
por: Leung, W K, et al.
Publicado: (2005)

Promoter hypermethylation of the SFRP2 gene is a high-frequent alteration and tumor-specific epigenetic marker in human breast cancer
por: Veeck, Jürgen, et al.
Publicado: (2008)

The Prognostic Value of Pyrosequencing-Detected MGMT Promoter Hypermethylation in Newly Diagnosed Patients with Glioblastoma
por: Villani, Veronica, et al.
Publicado: (2015)

RASSF1A hypermethylation in pretreatment serum DNA of neuroblastoma patients: a prognostic marker
por: Misawa, A, et al.
Publicado: (2009)

Low Levels of BNIP3 Promoter Hypermethylation in Invasive Breast Cancer
por: van Diest, Paul J., et al.
Publicado: (2010)

Validation of SFRP1 Promoter Hypermethylation in Plasma as a Prognostic Marker for Survival and Gemcitabine Effectiveness in Patients with Stage IV Pancreatic Adenocarcinoma
por: Stubbe, Benjamin Emil, et al.
Publicado: (2021)

APC Promoter Methylation in Gastrointestinal Cancer
por: Zhu, Lila, et al.
Publicado: (2021)

DNA hypermethylation markers of poor outcome in laryngeal cancer
por: Stephen, Josena K., et al.
Publicado: (2010)

Upregulation of anaphase promoting complex (APC) 7 as a prognostic marker for esophageal squamous cell carcinoma: A hospital based study
por: Ali, Eyashin, et al.
Publicado: (2022)

Hypermethylated genes as biomarkers of breast cancer
por: Fackler, MJ, et al.
Publicado: (2009)

CDH1 promoter hypermethylation and E-cadherin protein expression in infiltrating breast cancer
por: Caldeira, José Roberto F, et al.
Publicado: (2006)

Promoter hypermethylation in male breast cancer: analysis by multiplex ligation-dependent probe amplification
por: Kornegoor, Robert, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_76mf39gc1a6226lfgmrc2fvvlu